There is a whole lot of research going on using stem cells to repair the heart.
This UK study is just one of them. Neostem (Nasdaq: NBS) has completed enrolment in a Phase II study so I expect it would be much further advanced than the UK group. Here is a link to a Neostem press release which is quite interesting, especially about their share price.
http://www.neostem.com/media/press-...rther-information-regarding-phase-2-preserve/
Here also is a link to a SA article comparing Neostem stem cell therapy to Sunshine Heart’s C-Pulse.
http://seekingalpha.com/article/169...e-heart-complementary-not-competing-therapies
I would say stem cell therapy has much further to go than C-Pulse. And its efficacy has not been demonstrated in the way C-Pulse has.
- Forums
- ASX - By Stock
- SHC
- stem cells
stem cells, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales